Literature DB >> 12145165

Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells.

Karsten Buschard1, Marianne Høy, Krister Bokvist, Hervør L Olsen, Sten Madsbad, Pam Fredman, Jesper Gromada.   

Abstract

The glycosphingolipid sulfatide is present in secretory granules and at the surface of pancreatic beta-cells, and antisulfatide antibodies (ASA; IgG1) are found in serum from the majority of patients with newly diagnosed type 1 diabetes. Here we demonstrate that sulfatide produced a glucose- and concentration-dependent inhibition of insulin release from isolated rat pancreatic islets. This inhibition of insulin secretion was due to activation of ATP-sensitive K(+)-(K(ATP)) channels in single rat beta-cells. No effect of sulfatide was observed on whole-cell Ca(2+)-channel activity or glucose-induced elevation of cytoplasmic Ca(2+) concentration. It is interesting that sulfatide stimulated Ca(2+)-dependent exocytosis determined by capacitance measurements and depolarized-induced insulin secretion from islets exposed to diazoxide and high external KCl. The monoclonal sulfatide antibody Sulph I as well as ASA-positive serum reduced glucose-induced insulin secretion by inhibition of Ca(2+)-dependent exocytosis. Our data suggest that sulfatide is important for the control of glucose-induced insulin secretion and that both an increase and a decrease in the sulfatide content have an impact on the secretory capacity of the individual beta-cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145165     DOI: 10.2337/diabetes.51.8.2514

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  Involvement of sulfatide in beta cells and type 1 and type 2 diabetes.

Authors:  K Buschard; M Blomqvist; T Osterbye; P Fredman
Journal:  Diabetologia       Date:  2005-09-06       Impact factor: 10.122

Review 2.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

3.  Phosphatidylinositol 4-kinase serves as a metabolic sensor and regulates priming of secretory granules in pancreatic beta cells.

Authors:  Hervør L Olsen; Marianne Hoy; Wei Zhang; Alejandro M Bertorello; Krister Bokvist; Kirsten Capito; Alexander M Efanov; Björn Meister; Peter Thams; Shao-Nian Yang; Patrik Rorsman; Per-Olof Berggren; Jesper Gromada
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

4.  Ca2+-induced effect on mechanical properties of sulfatide-incorporated vesicles.

Authors:  Jin-Won Park
Journal:  J Membr Biol       Date:  2010-11-19       Impact factor: 1.843

5.  Regulatory effect of sulphatides on BKCa channels.

Authors:  S Chi; Z Qi
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

6.  Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥ 32.5 kg/m(2.).

Authors:  Jian Yang; Xiao Feng; Shuzhe Zhong; Yong Wang; Jingang Liu
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

7.  Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.

Authors:  Karsten Buschard
Journal:  Med Hypotheses       Date:  2020-07-21       Impact factor: 1.538

8.  Sulfatide is associated with insulin granules and located to microdomains of a cultured beta cell line.

Authors:  Maria Blomqvist; Thomas Osterbye; Jan-Eric Månsson; Thomas Horn; Karsten Buschard; Pam Fredman
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

Review 9.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013

Review 10.  Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction.

Authors:  Ebru Boslem; Peter J Meikle; Trevor J Biden
Journal:  Islets       Date:  2012 May-Jun       Impact factor: 2.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.